Cargando…
Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome
We enrolled consecutive IBS-M patients (n = 25) according to Rome IV criteria. Fecal samples were obtained from all patients twice (pre-and post-intervention) and high-throughput 16S rRNA sequencing was performed. Six weeks of personalized nutrition diet (n = 14) for group 1 and a standard IBS diet...
Autores principales: | Karakan, Tarkan, Gundogdu, Aycan, Alagözlü, Hakan, Ekmen, Nergiz, Ozgul, Seckin, Tunali, Varol, Hora, Mehmet, Beyazgul, Damla, Nalbantoglu, O. Ufuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629088/ https://www.ncbi.nlm.nih.gov/pubmed/36318623 http://dx.doi.org/10.1080/19490976.2022.2138672 |
Ejemplares similares
-
Efficacy of AI-Assisted Personalized Microbiome Modulation by Diet in Functional Constipation: A Randomized Controlled Trial
por: Arslan, Naciye Çiğdem, et al.
Publicado: (2022) -
Human genome-microbiome interaction: metagenomics frontiers for the aetiopathology of autoimmune diseases
por: Gundogdu, Aycan, et al.
Publicado: (2017) -
COVID-19 Pandemic: Group Testing
por: Nalbantoglu, Ozkan Ufuk, et al.
Publicado: (2020) -
Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: McFarland, Lynne V., et al.
Publicado: (2021) -
Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology
por: Gocun, Pınar Uyar, et al.
Publicado: (2022)